ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
Background. Luminal tumors account for 65 % of all breast cancer (BC) cases; however, within this group, there are multiple subtypes with various clinical and morphological characteristics, disease course and prognosis. Choosing an optimal strategy for adjuvant chemotherapy (ACT) in postmenopausal w...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2017-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|